Andrew Ashe - Dyax Corp Insider

Dyax Corp -- USA Stock  

USD 38.41  0.00  0.00%

Executive VP, General Counsel and Secretary

Mr. Andrew Ashe is Executive Vice President and General Counsel of Dyax Corporationration since March 25 2013. He joined Dyax in 2003 and served as an attorney in our legal department until 2011 when he became our General Counsel. Mr. Ashe now manages the Companys legal intellectual property and compliance activities and also oversees the human resources facilities and information technology departments within Dyax. He also serves as the Companys Corporationrationrate Secretary. Prior to joining Dyax Mr. Ashe practiced law as a corporate attorney at Nutter McClennen Fish and Prince Lobel Tye two private law firms based in Boston Massachusetts. Previously he also worked as a specialist and senior options analyst at the American Stock Exchange in New York
Age: 47  EVP Since 2013      
617-225-2500  http://www.dyax.com
Ashe received his law degree from The George Washington School of Law and a Bachelors in Business Administration from the University of Massachusetts, Amherst.

Andrew Ashe Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (0.06) % which means that it has lost $0.06 on every $100 spent on asset. This is way below average.
The company currently holds 82.17 M in liabilities with Debt to Equity (D/E) ratio of 0.26 which may suggest the company is not taking enough advantage from borrowing. Dyax Corp has Current Ratio of 11.43 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Entity Summary

Dyax Corporation, a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema and other plasmakallikreinmediated disorders. Dyax Corp (DYAX) is traded on NASDAQ General Markets in USA. It is located in MASSACHUSETTS, U.S.A and employs 124 people. Dyax Corp is listed under Business Services category by Fama And French industry classification.

Did you try this?

Run Portfolio Reporting Now
   

Portfolio Reporting

Create custom reports across your portfolios and generate quick suggestion pitch
Hide  View All  Next  Launch Portfolio Reporting
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Dyax Corp to your portfolio

Top Management

Dyax Corp Leadership Team
Thomas Kempner, Director
Henry Blair, Chairman
Jennifer Robinson, Director
James Fordyce, Director
Marc Kozin, Director, MBA
Mary Gray, Director, Ph.D
Paolo Pucci, Director, MBA
George Migausky, CFO, MBA
Andrew Ashe, EVP
Abbie Celniker, Director, Ph.D
Ron Cohen, Director
Burt Adelman, President, Ph.D
Gustav Christensen, CEO, MBA
Todd Bazemore, President
David McLachlan, Director

Stock Performance

Dyax Corp Performance Indicators